/CNW/ - Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO) (OTCQX: HCANF formerly AGEEF) (Germany: A9KN) is pleased to announce further imports of.
/CNW/ - Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO, OTCQX: HCANF, Germany: A9KN) is pleased to announce that the Underwriters (as defined below).
Not for Distribution to U.S. Newswire Services or For Dissemination in the United StatesAll figures in USD unless stated otherwise TORONTO, Feb. 6, 2021 /CNW/ - Halo Collective Inc. is delighted. | February 11, 2021
Share this article
VANCOUVER, BC, Feb. 5, 2021 /PRNewswire/ -
InMed Pharmaceuticals Inc. ( InMed or the Company ) (Nasdaq:INM) (TSX:IN), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol ( CBN ), today announced today announced that it has entered into definitive agreements with certain institutional investors to raise aggregate gross proceeds of approximately US$4.5 million at a price of US$4.25 per unit in a private placement of its equity securities. Each unit consists of one common share and 0.66 of a warrant to purchase one common share. Each whole warrant has an exercise price of US$4.85 per share, is exercisable six months following issuance and has a term of five and one half years following issuance. After the placement agent fees and estimated offering expenses payable by the Company, the Company expects to receive net proceeds of approximately US$4.0 mil
Share:
All figures in USD unless stated otherwise
The triad of Hushrooms™ formulations will be available for purchase throughout the U.S. at shroommart.com
TORONTO, Feb. 4, 2021 /CNW/ - Halo Collective Inc. (
Halo or the
Company ) (NEO: HALO) (OTCQX:HCANF) (Germany: A9KN) is pleased to announce the entering into of a partnership with Nightingale Remedies (
Nightingale ) and PeakBirch Logic Inc. (
PeakBirch ) (CSE:PKB, OTCQX:KTNNF, Germany: KYH2)), leveraging the group s formulation, manufacturing, and e-commerce expertise to develop and launch a line of products combining functional, health and wellness attributes of mushrooms, without psychoactive or psychedelic properties.
Formulations will be spearheaded by Halo s wholly-owned subsidiary, Halo Peripherals, and Nightingale a premier consumer-driven, non-psychoactive, cannabinoid product development and manufacturing company. Together with leading e-commerce retailer PeakBirch, the combined efforts are expected to